IPA (ImmunoPrecise Antibodies) is a Contract Research Organization (CRO) with end-to-end technology solutions empowering clients in the discovery and development of antibody therapeutics and diagnostics. We serve our partners through a multi-national, integrated network of facilities in North America and Europe. This enables us to offer a comprehensive range of antibody discovery and development services including, for example, custom antibody generation, in silico analysis, antibody characterization, engineering, manufacturing, and humanization. Located in North America and Europe, IPA serves many of the world’s top biotech and pharmaceutical companies in the common mission of conquering life-threatening diseases.